You are here

  • Home
  • Archive
  • Volume 96, Issue Suppl 1
  • 061 Metabolic alteration in hypertrophic cardiomyopathy (METAL-HCM Study): randomised double blinded placebo controlled trial of perhexiline therapy in patient with hypertrophic cardiomyopathy

Citation Tools

Article menu
Download PDFPDF
BCS Abstracts 2010
Abstract
061 Metabolic alteration in hypertrophic cardiomyopathy (METAL-HCM Study): randomised double blinded placebo controlled trial of perhexiline therapy in patient with hypertrophic cardiomyopathy

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Abozguia K, Elliott P, McKenna W, et al
061 Metabolic alteration in hypertrophic cardiomyopathy (METAL-HCM Study): randomised double blinded placebo controlled trial of perhexiline therapy in patient with hypertrophic cardiomyopathy
Heart 2010;96:A36.